Subsequently, a retargeted Ad vector was generated as a model using an adapter molecule, which was constructed through the genetic fusion of SpyCatcher with a nanobody specific to vascular endothelial growth factor receptor-2 (VEGFR2), as one of the main targets for the inhibition of tumor angiogenesis. This evidence concerns the gene KDR and neoplasm.